Project Data Sphere enables wide use of clinical trial data

Project Data Sphere enables wide use of clinical trial data

Project Data Sphere enables wide use of clinical trial data

Despite the billions of private and federal dollars spent on cancer research each year, it is estimated that nearly one in every three people will hear a cancer diagnosis in their lifetime.

Project Data Sphere, a digital library-laboratory platform, collects data from clinical trials and makes it available to the public for secondary analysis in the hopes of finding a cure.

However, the data comes from an unlikely partner—big pharma.

“There are some companies out there that see this as they’re giving away their intellectual property and, to an extent, they are,” says Matt Gross, director of the SAS Health Care and Life Sciences Global Practice. “If nothing else, they’re giving away literally billions of dollars of time, money and effort in the collection of this information and making it available to the public.”

Gross adds that this willingness amongst competitors to share proprietary information for the greater good reflects an evolution in healthcare. But it took a lot of work to even get representatives from competing companies in the same room.

Read Also:
How Big Data Is Changing Conventional Lending

Martin J. Murphy, founding chief information officer of the CEO Roundtable on Cancer, which funds Project Data Sphere, says pharmaceutical companies were initially worried about counterintelligence if they were to set a meeting.

“There was a lot of fear, but not a lot of basis for it,” he says. “You could see people were getting uncomfortable. ‘We never shared that data. Why should we start?’ ”

It took a Department of Justice representative to sit in on a meeting with the CEO Roundtable on Cancer for the pharmaceutical companies to realize “certain things can and should be done together,” Murphy says.

The nonprofit launched Project Data Sphere in April 2014, and partnered with SAS to create an analytics toolkit. Third-party researchers, along with the general public, can log in to the platform and look through completed clinical trials for broader research beyond the pharmaceutical companies’ original intent for conducting the trials.

There are currently more than 900 authorized users on the platform with access to 49 datasets representing 27,000 patient lives across a broad array of cancer tumor areas.

Read Also:
Big Data For Motivation And Team Building


Chief Analytics Officer Spring 2017

2
May
2017
Chief Analytics Officer Spring 2017

15% off with code MP15

Read Also:
Do you need a Chief Artificial Intelligence Officer (CAIO)?

Big Data and Analytics for Healthcare Philadelphia

17
May
2017
Big Data and Analytics for Healthcare Philadelphia

$200 off with code DATA200

Read Also:
What Healthcare Analytics Can Teach The Rest of Us

SMX London

23
May
2017
SMX London

10% off with code 7WDATASMX

Read Also:
Eight obstacles to overcome in your digital transformation journey

Data Science Congress 2017

5
Jun
2017
Data Science Congress 2017

20% off with code 7wdata_DSC2017

Read Also:
How Data Science Will Change IT Operations

AI Paris

6
Jun
2017
AI Paris

20% off with code AIP17-7WDATA-20

Read Also:
Master Data Management Moves Past the Hype Cycle

Leave a Reply

Your email address will not be published. Required fields are marked *